ID11916

Skip to product information
1 of 1

Selleck Chemicals

SKU:E8283-1MG

Regular price €390,00 EUR
Regular price Sale price €390,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

ID11916 is an inhibitor of Androgen Receptor used in studies of Hormone Signaling. It is especially relevant in cancer and endocrinology models, where defined compound exposure can be linked to ligand-dependent transcriptional programs and endocrine regulation.

By inhibiting Androgen Receptor, ID11916 can be used to examine ligand-dependent transcriptional programs and endocrine regulation. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In cancer and endocrinology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving Androgen Receptor
  • Pathway perturbation studies connected to Hormone Signaling
  • Concentration-response inhibition and target-dependence studies
  • Reporter-gene, receptor-binding, and transcriptional assays

Overall, ID11916 is appropriate when a defined chemical perturbant is needed to connect Androgen Receptor with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer and endocrinology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
Androgen Receptor
Target Class:
Nuclear Receptor
Pathways:
Hormone Signaling
Research Area:
Cancer • Endocrinology
CAS No.:
2785317-21-5
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.